1.
Med Tr Prom Ekol
; (1): 7-11, 2011.
Article
in Russian
| MEDLINE
| ID: mdl-21446069
ABSTRACT
Recommendations for patients with occupational locomotory disorders include ultrasonography, diagnostic and therapeutic arthroscopy, target therapy of systemic osteoporosis with monohydrate zoledronic acid (aclasta)--that enables prolong remission (up to 46.2 months).